Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High-Density Lipoprotein
Eric J. Niesor, Gregory G. Schwartz, Anne Perez et al. · Cardiovascular Drugs and Therapy · 2015
Cited by 69 works. doi:10.1007/s10557-015-6570-0
Authors
- Eric J. Niesor
- Gregory G. Schwartz
- Anne Perez
- Andrea Stauffer
- Alexandre Durrwell
- Gabriela Suchánková
- Renée Benghozi
- Markus Abt
- David G. Kallend
References
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- Protein Sensors for Membrane Sterols
- Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
- MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
- ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages
- Cholesterol Efflux and Atheroprotection